Compass Therapeutics

CMPXNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$125.143 M

$0.69 -8.89%

Close of 6 Nov 2026

As of 6 Nov 2026, Compass Therapeutics (CMPX) has a market capitalization of $125.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$66.5M

Loss-making

Shares outstanding

180,087,915

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#101Sutro BiopharmaSTRO$152.0M
#102Protara TherapeuticsTARA$125.9M
#103Compass TherapeuticsCMPX$125.1M
#104Molecular PartnersMOLN$120.6M
#105Coherus OncologyCHRS$115.9M

What if Compass Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$156,794.94

Per share 225,637× higher

Bitcoin $1.53T

$8,483.90

Per share 12,209× higher

Apple $5.02T

$27,851.86

Per share 40,080× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Compass Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.